← Leaderboards
Michael Lucy
University Of Pennsylvania
$248,292
Attributed
$248,292
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$248,292 · 1
By mechanism
M01$248,292 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Peter J. Snyder$40,848,094
- Rob R Macgregor$4,980,820
- Jane B Alavi$1,520,103
- Daniel Sterman$5,215,085
- David A Mankoff$17,196,499
Others in their field
Top investigators on “Arginine Vasopressin”
- Carol Sue Carter · University Of Maryland College Pk Campus$7,999,661
- Karen J. Parker · University Of Chicago$5,676,663
- Steven H Liang · Emory University$4,624,148
- Steven A. Siegelbaum · Columbia University Health Sciences$3,731,177
- Kenneth L Byron · Loyola University Chicago$3,586,056
- Pat R Levitt · University Of Pittsburgh At Pittsburgh$2,974,525
Research focus
Arginine VasopressinAscitesAzepinesClinical ResearchClinical Trial Phase IDrug Screening /EvaluationHormone InhibitorHormone TherapyHuman SubjectHuman Therapy EvaluationLiver CirrhosisLiver Disorder ChemotherapyPharmacokinetics
Grant awards (6)
VPA-985 ADMINISTERED TO PATIENTS WITH LIVER CIRRHOSIS AND ASCITES$124,146
M01 · FY2002 · RR
VPA-985 ADMINISTERED TO PATIENTS WITH LIVER CIRRHOSIS AND ASCITES$124,146
M01 · FY2001 · RR
VPA-985 ADMINISTERED TO PATIENTS WITH LIVER CIRRHOSIS AND ASCITES$0
M01 · FY2001 · RR
VPA-985 ADMINISTERED TO PATIENTS WITH LIVER CIRRHOSIS AND ASCITES$0
M01 · FY2000 · RR
VPA-985 ADMINISTERED TO PATIENTS WITH LIVER CIRRHOSIS AND ASCITES$0
M01 · FY2000 · RR
VPA-985 ADMINISTERED TO PATIENTS WITH LIVER CIRRHOSIS AND ASCITES$0
M01 · FY2000 · RR